Obesity and Adipose-Derived Extracellular Vesicles: Implications for Metabolic Regulation and Disease
Biomolecules · 05.02.2025 · 15 (2) · 231
DOI: 10.3390/biom15020231 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 05.02.2025. Verfasst von Michele Malaguarnera und 2 weiteren Autor:innen. Beteiligte Einrichtung: Psychobiology Department, University of Valencia, 46010 Valencia, Spain. Hauptthemen laut MEDLINE: Extracellular Vesicles, Obesity, Adipose Tissue. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III (ISCIII), the European Union and Conselleria de Educación/Innovación, Universidades, Ciencia y Sociedad Digital, subvenciones para la realización de proyectos de I + D +…, the European Union and Conselleria de Educación/Innovación, Universidades, Ciencia y Sociedad Digital.
Abstract (Originalsprache)
Obesity, a global epidemic, is a major risk factor for chronic diseases such as type 2 diabetes, cardiovascular disorders, and metabolic syndrome. Adipose tissue, once viewed as a passive fat storage site, is now recognized as an active endocrine organ involved in metabolic regulation and inflammation. In obesity, adipose tissue dysfunction disrupts metabolic balance, leading to insulin resistance and increased production of adipose-derived extracellular vesicles (AdEVs). These vesicles play a key role in intercellular communication and contribute to metabolic dysregulation, affecting organs such as the heart, liver, and brain. AdEVs carry bioactive molecules, including microRNAs, which influence inflammation, insulin sensitivity, and tissue remodeling. In the cardiovascular system, AdEVs can promote atherosclerosis and vascular dysfunction, while those derived from brown adipose tissue offer cardioprotective effects. In type 2 diabetes, AdEVs exacerbate insulin resistance and contribute to complications such as diabetic cardiomyopathy and cognitive decline. Additionally, AdEVs are implicated in metabolic liver diseases, including fatty liver disease, by transferring inflammatory molecules and lipotoxic microRNAs to hepatocytes. These findings highlight the role of AdEVs in obesity-related metabolic disorders and their promise as therapeutic targets for related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Psychobiology Department, University of Valencia, 46010 Valencia, Spain.
- Nursing Department, University of Valencia, 46010 Valencia, Spain.
- Frailty Research Organized Group (FROG), University of Valencia, 46010 Valencia, Spain.
- Pharmacology Department, University of Valencia, 46010 Valencia, Spain.
- Fundación de Investigación del Hospital Clínico Universitario de Valencia (INCLIVA), 46010 Valencia, Spain.
ORCID-Profile: Omar Cauli, Andrea Cabrera-Pastor
Förderung
- Instituto de Salud Carlos III (ISCIII)
- the European Union and Conselleria de Educación/Innovación, Universidades, Ciencia y Sociedad Digital, subvenciones para la realización de proyectos de I + D +…
- the European Union and Conselleria de Educación/Innovación, Universidades, Ciencia y Sociedad Digital
Zitieren
APA
Malaguarnera, M., Cauli, O., & Cabrera-Pastor, A. (2025). Obesity and Adipose-Derived Extracellular Vesicles: Implications for Metabolic Regulation and Disease. Biomolecules, 15(2), 231. https://doi.org/10.3390/biom15020231
Vancouver
Malaguarnera M, Cauli O, Cabrera-Pastor A. Obesity and Adipose-Derived Extracellular Vesicles: Implications for Metabolic Regulation and Disease. Biomolecules. 2025;15(2):231. doi:10.3390/biom15020231
BibTeX
@article{Malaguarnera2025,
author = {Malaguarnera, Michele and Cauli, Omar and Cabrera-Pastor, Andrea},
title = {Obesity and Adipose-Derived Extracellular Vesicles: Implications for Metabolic Regulation and Disease},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {2},
pages = {231},
doi = {10.3390/biom15020231}
}
EUVIMED